What is F/m Emerald Life Sciences Innovation ETF share price today?
F/m Emerald Life Sciences Innovation ETF (LFSC) is currently trading at $46.15. You can also track daily change, historical performance, trading volume and other key ETF details on this page.How can I buy F/m Emerald Life Sciences Innovation ETF shares from India?
Indian investors can buy F/m Emerald Life Sciences Innovation ETF (LFSC) by opening a US investing account through a platform that provides access to US stocks and ETFs, completing the required verification, transferring funds under the Liberalised Remittance Scheme (LRS), and placing an order in USD.Can Indians/NRIs invest in F/m Emerald Life Sciences Innovation ETF from India?
Yes, Indian residents and NRIs can invest in F/m Emerald Life Sciences Innovation ETF (LFSC) through platforms that offer access to US-listed stocks and ETFs, subject to applicable regulations, including RBI’s Liberalised Remittance Scheme (LRS) guidelines.What is the expense ratio of F/m Emerald Life Sciences Innovation ETF?
The expense ratio of F/m Emerald Life Sciences Innovation ETF (LFSC) is N/A. It represents the annual operating cost charged by the ETF provider for managing the fund and tracking its underlying index.What are F/m Emerald Life Sciences Innovation ETF’s top holdings?
F/m Emerald Life Sciences Innovation ETF (LFSC)’s top holdings currently include Travere Therapeutics Inc, Corcept Therapeutics Incorporated, and Spyre Therapeutics Inc.. The ETF’s complete holdings list, allocation and sector exposure are available in the Holdings section on this page.Can I buy fractional shares of F/m Emerald Life Sciences Innovation ETF?
Many platforms offering US ETF investing allow fractional investing, enabling Indian investors to buy a portion of F/m Emerald Life Sciences Innovation ETF (LFSC) instead of a full share. This allows investment based on a fixed dollar amount.What are the tax implications of investing in F/m Emerald Life Sciences Innovation ETF for Indian investors?
Gains from F/m Emerald Life Sciences Innovation ETF (LFSC) are generally taxed in India based on the applicable holding period and tax rules. Dividends may be subject to US withholding tax and Indian taxation rules. The final tax treatment depends on individual circumstances.Is there a TCS on remitting money to buy F/m Emerald Life Sciences Innovation ETF under LRS?
Remittances under the Liberalised Remittance Scheme (LRS) for overseas investments, including US ETFs like F/m Emerald Life Sciences Innovation ETF (LFSC), may attract TCS above specified thresholds. Applicable rates and limits are determined by government regulations and may change over time.What is F/m Emerald Life Sciences Innovation ETF’s AUM (assets under management)?
F/m Emerald Life Sciences Innovation ETF (LFSC)’s current assets under management (AUM) are $126.06M. AUM represents the total market value of assets managed by the ETF and indicates the size of the fund.What is F/m Emerald Life Sciences Innovation ETF’s P/E ratio?
F/m Emerald Life Sciences Innovation ETF (LFSC)’s price-to-earnings (P/E) ratio is 27.76. It represents the weighted valuation of the companies held within the ETF relative to their earnings.How does F/m Emerald Life Sciences Innovation ETF compare with Health Care Select Sector SPDR® Fund (XLV), Vanguard Health Care Index Fund ETF Shares (VHT), and SPDR® S&P Biotech ETF (XBI)?
You can compare F/m Emerald Life Sciences Innovation ETF (LFSC) with Health Care Select Sector SPDR® Fund (XLV), Vanguard Health Care Index Fund ETF Shares (VHT), and SPDR® S&P Biotech ETF (XBI) based on metrics such as expense ratio, AUM, P/E ratio, holdings, liquidity and historical returns in the Peers & Comparison section.What is F/m Emerald Life Sciences Innovation ETF’s NAV (net asset value) today?
F/m Emerald Life Sciences Innovation ETF (LFSC)’s NAV represents the per-unit value of the ETF’s underlying holdings after adjusting for expenses and liabilities. It is calculated once daily after markets close and may differ from the ETF’s live market price.
$
₹
$46.150.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
Expense Ratio
Expense Ratio
The operating and administrative costs of running the fund measured as the percentage of fund assets
—
AUM
AUM
Current market value of the ETF scheme managed by the Asset Management Company
$126.06M
Beta
Beta
Sensitivity of the stock's price relative to the country's key indices over the last 5 years
0
Volatility (3Y)
Volatility (3Y)
The annualized standard deviation of the ETF's returns calculated over the last 3 years
0%
PE
PE
Ratio of price to the prospective earnings of the ETF's underlyings
27.76
PE Category
PE Category
Ratio of price to the prospective earnings of the holdings of ETFs from the same category
21.17
ETF Profile
Peers
Peers
Exp. Ratio
0.09%
0.09%
PE
20.21
20.21
—
—
1Y Return
25.32%
25.32%
—
—
Exp. Ratio
0.1%
0.1%
PE
19.57
19.57
—
—
1Y Return
26.31%
26.31%
—
—
Exp. Ratio
0.35%
0.35%
PE
21.31
21.31
—
—
1Y Return
75.3%
75.3%
—
—
Exp. Ratio
0.4499%
0.4499%
PE
19.83
19.83
—
—
1Y Return
51.08%
51.08%
—
—
Exp. Ratio
0.42%
0.42%
PE
18.88
18.88
—
—
1Y Return
19.36%
19.36%
—
—
Peers & Comparison
Peers & Comparison
ETFHealth
| ETF | Total AUMTotal AUM | Exp. RatioExp. Ratio | 1Y Return1Y Return |
|---|---|---|---|
| F/m Emerald Life Sciences Innovation ETF | $126.06M | - | 61.70% |
| Health Care Select Sector SPDR® Fund | $44.50B | 0.09% | 25.32% |
| Vanguard Health Care Index Fund ETF Shares | $19.40B | 0.1% | 26.31% |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Top Holdings
Top Holdings
- NameHoldingsSector
- Travere Therapeutics IncSector: HealthcareHoldings8.70 %Travere Therapeutics IncTVTX
Holdings
8.70 %
Healthcare - Corcept Therapeutics IncorporatedSector: HealthcareHoldings6.72 %Corcept Therapeutics IncorporatedCORT
Holdings
6.72 %
Healthcare - Spyre Therapeutics Inc.Sector: HealthcareHoldings6.69 %Spyre Therapeutics Inc.SYRE
Holdings
6.69 %
Healthcare - LivaNova PLCSector: HealthcareHoldings6.61 %LivaNova PLCLIVN
Holdings
6.61 %
Healthcare - Cogent Biosciences IncSector: HealthcareHoldings6.47 %Cogent Biosciences IncUMRX
Holdings
6.47 %
Healthcare - Mirum Pharmaceuticals IncSector: HealthcareHoldings4.32 %Mirum Pharmaceuticals IncMIRM
Holdings
4.32 %
Healthcare - BillionToOne, Inc. Class A Common StockSector: HealthcareHoldings3.85 %BillionToOne, Inc. Class A Common StockBLLN
Holdings
3.85 %
Healthcare - Guardant Health IncSector: HealthcareHoldings3.81 %Guardant Health IncGH
Holdings
3.81 %
Healthcare - Cytokinetics IncSector: HealthcareHoldings3.49 %Cytokinetics IncCYTK
Holdings
3.49 %
Healthcare - United Therapeutics CorporationSector: HealthcareHoldings3.27 %United Therapeutics CorporationUTHR
Holdings
3.27 %
Healthcare